Abstract:Objective To evaluate the expression of cyclooxygenase2(Cox-2) in human colorectal carcinoma and its correlations with clinicopathologic parameters and disease prognosis. Methods Tissue samples from 84 patients with disease of primary colorectal carcinoma were immunohistochemically examined for cyclooxygenase 2 expression. Then, we analyzed the correlations with clinicopathologic findings and patients survival time. Results Expression of Cox-2 was positive in 72.6% of primary tumor, 6.7% of peritumor tissue, and negative in the normal mucosa. Expression of Cox-2 was significantly associated with depth of invasion(χ2=4.56, P<0.05), lymph node metastases(χ2=3.93, P<0.05) and distant metastases(χ2=6.63, P<0.05). Patients with Cox-2 positive tumors had a significant shorter survival time than those with negative Cox-2( P<0.05).Conclusions These data show that in human colorectal carcinoma, Cox-2 is significantly associated with clinicopathologic parameters and disease prognosis.

Expression of cyclooxygenase 2 in colorectal cancer